UniProt ID | PKHA2_HUMAN | |
---|---|---|
UniProt AC | Q9HB19 | |
Protein Name | Pleckstrin homology domain-containing family A member 2 | |
Gene Name | PLEKHA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 425 | |
Subcellular Localization |
Cytoplasm. Cell membrane Peripheral membrane protein. Nucleus. Locates to the plasma membrane after treatments that stimulate the production of PtdIns3,4P2.. |
|
Protein Description | Binds specifically to phosphatidylinositol 3,4-diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane (By similarity).. | |
Protein Sequence | MPYVDRQNRICGFLDIEEHENSGKFLRRYFILDTQANCLLWYMDNPQNLAMGAGAVGALQLTYISKVSIATPKQKPKTPFCFVINALSQRYFLQANDQKDMKDWVEALNQASKITVPKGGGLPMTTEVLKSLAAPPALEKKPQVAYKTEIIGGVVVHTPISQNGGDGQEGSEPGSHTILRRSQSYIPTSGCRASTGPPLIKSGYCVKQGNVRKSWKRRFFALDDFTICYFKCEQDREPLRTIFLKDVLKTHECLVKSGDLLMRDNLFEIITSSRTFYVQADSPEDMHSWIKEIGAAVQALKCHPRETSFSRSISLTRPGSSSLSSGPNSILCRGRPPLEEKKALCKAPSVASSWQPWTPVPQAGEKLLPPGDTSEDSLFTPRPGEGAPPGVLPSSRIRHRSEPQHPKEKPFMFNLDDENIRTSDV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
29 | Phosphorylation | SGKFLRRYFILDTQA CCCHHHHEEEEECCC | 6.63 | 22817900 | |
73 | Ubiquitination | KVSIATPKQKPKTPF EEEECCCCCCCCCCC | 67.60 | - | |
99 | Ubiquitination | FLQANDQKDMKDWVE HHCCCCCHHHHHHHH | 63.75 | - | |
102 | Sumoylation | ANDQKDMKDWVEALN CCCCHHHHHHHHHHH | 59.58 | - | |
102 | Sumoylation | ANDQKDMKDWVEALN CCCCHHHHHHHHHHH | 59.58 | - | |
102 | Ubiquitination | ANDQKDMKDWVEALN CCCCHHHHHHHHHHH | 59.58 | - | |
113 | Ubiquitination | EALNQASKITVPKGG HHHHHHHCCCCCCCC | 45.47 | - | |
115 | Phosphorylation | LNQASKITVPKGGGL HHHHHCCCCCCCCCC | 34.20 | 24719451 | |
118 | Sumoylation | ASKITVPKGGGLPMT HHCCCCCCCCCCCCC | 66.89 | - | |
118 | Ubiquitination | ASKITVPKGGGLPMT HHCCCCCCCCCCCCC | 66.89 | - | |
118 | Sumoylation | ASKITVPKGGGLPMT HHCCCCCCCCCCCCC | 66.89 | - | |
126 | Phosphorylation | GGGLPMTTEVLKSLA CCCCCCCHHHHHHCC | 20.18 | - | |
130 | Ubiquitination | PMTTEVLKSLAAPPA CCCHHHHHHCCCCHH | 48.91 | - | |
131 | Phosphorylation | MTTEVLKSLAAPPAL CCHHHHHHCCCCHHH | 21.05 | 28555341 | |
140 | Ubiquitination | AAPPALEKKPQVAYK CCCHHHHCCCCEEEE | 71.28 | - | |
141 | Sumoylation | APPALEKKPQVAYKT CCHHHHCCCCEEEEE | 31.16 | 25218447 | |
141 | Ubiquitination | APPALEKKPQVAYKT CCHHHHCCCCEEEEE | 31.16 | - | |
141 | Sumoylation | APPALEKKPQVAYKT CCHHHHCCCCEEEEE | 31.16 | - | |
158 | Phosphorylation | IGGVVVHTPISQNGG ECEEEEECCCCCCCC | 15.65 | 28555341 | |
161 | Phosphorylation | VVVHTPISQNGGDGQ EEEECCCCCCCCCCC | 20.85 | 28857561 | |
175 | Phosphorylation | QEGSEPGSHTILRRS CCCCCCCCCCEEECC | 28.33 | 28555341 | |
182 | Phosphorylation | SHTILRRSQSYIPTS CCCEEECCCCCCCCC | 19.62 | 21945579 | |
184 | Phosphorylation | TILRRSQSYIPTSGC CEEECCCCCCCCCCC | 26.69 | 22167270 | |
185 | Phosphorylation | ILRRSQSYIPTSGCR EEECCCCCCCCCCCC | 11.86 | 21945579 | |
188 | Phosphorylation | RSQSYIPTSGCRAST CCCCCCCCCCCCCCC | 28.35 | 21945579 | |
189 | Phosphorylation | SQSYIPTSGCRASTG CCCCCCCCCCCCCCC | 30.46 | 21945579 | |
194 | Phosphorylation | PTSGCRASTGPPLIK CCCCCCCCCCCCEEE | 17.97 | 26657352 | |
195 | Phosphorylation | TSGCRASTGPPLIKS CCCCCCCCCCCEEEC | 53.36 | 26552605 | |
201 | Sumoylation | STGPPLIKSGYCVKQ CCCCCEEECCEEEEC | 45.57 | - | |
201 | Ubiquitination | STGPPLIKSGYCVKQ CCCCCEEECCEEEEC | 45.57 | - | |
201 | Sumoylation | STGPPLIKSGYCVKQ CCCCCEEECCEEEEC | 45.57 | - | |
207 | Ubiquitination | IKSGYCVKQGNVRKS EECCEEEECCCCCHH | 49.26 | - | |
245 | Sumoylation | PLRTIFLKDVLKTHE CCHHHHHHHHHHHCH | 34.73 | - | |
245 | Ubiquitination | PLRTIFLKDVLKTHE CCHHHHHHHHHHHCH | 34.73 | - | |
249 | Ubiquitination | IFLKDVLKTHECLVK HHHHHHHHHCHHHHH | 47.92 | - | |
262 | Sulfoxidation | VKSGDLLMRDNLFEI HHCCCEEECCCCCHH | 7.04 | 21406390 | |
272 | Phosphorylation | NLFEIITSSRTFYVQ CCCHHHCCCCEEEEE | 13.86 | 21712546 | |
273 | Phosphorylation | LFEIITSSRTFYVQA CCHHHCCCCEEEEEC | 27.04 | 25627689 | |
291 | Ubiquitination | EDMHSWIKEIGAAVQ HHHHHHHHHHHHHHH | 36.70 | - | |
301 | Ubiquitination | GAAVQALKCHPRETS HHHHHHHHCCCCCCC | 33.25 | - | |
308 | Phosphorylation | KCHPRETSFSRSISL HCCCCCCCCCCEEEE | 19.24 | 30576142 | |
312 | Phosphorylation | RETSFSRSISLTRPG CCCCCCCEEEEECCC | 18.48 | 23927012 | |
314 | Phosphorylation | TSFSRSISLTRPGSS CCCCCEEEEECCCCC | 25.57 | 25463755 | |
316 | Phosphorylation | FSRSISLTRPGSSSL CCCEEEEECCCCCCC | 28.20 | 25463755 | |
320 | Phosphorylation | ISLTRPGSSSLSSGP EEEECCCCCCCCCCC | 21.31 | 23927012 | |
321 | Phosphorylation | SLTRPGSSSLSSGPN EEECCCCCCCCCCCC | 41.01 | 23927012 | |
322 | Phosphorylation | LTRPGSSSLSSGPNS EECCCCCCCCCCCCC | 33.69 | 23927012 | |
324 | Phosphorylation | RPGSSSLSSGPNSIL CCCCCCCCCCCCCCC | 34.89 | 23927012 | |
325 | Phosphorylation | PGSSSLSSGPNSILC CCCCCCCCCCCCCCC | 64.66 | 23927012 | |
329 | Phosphorylation | SLSSGPNSILCRGRP CCCCCCCCCCCCCCC | 21.77 | 28450419 | |
333 | Methylation | GPNSILCRGRPPLEE CCCCCCCCCCCCHHH | 40.48 | 80702641 | |
346 | Sumoylation | EEKKALCKAPSVASS HHHHHHHCCCCCHHC | 65.27 | - | |
346 | Ubiquitination | EEKKALCKAPSVASS HHHHHHHCCCCCHHC | 65.27 | - | |
346 | Sumoylation | EEKKALCKAPSVASS HHHHHHHCCCCCHHC | 65.27 | - | |
349 | Phosphorylation | KALCKAPSVASSWQP HHHHCCCCCHHCCCC | 34.86 | 28355574 | |
352 | Phosphorylation | CKAPSVASSWQPWTP HCCCCCHHCCCCCCC | 29.92 | 21712546 | |
353 | Phosphorylation | KAPSVASSWQPWTPV CCCCCHHCCCCCCCC | 21.72 | 30576142 | |
358 | Phosphorylation | ASSWQPWTPVPQAGE HHCCCCCCCCCCCCC | 22.53 | 26552605 | |
377 | Phosphorylation | PGDTSEDSLFTPRPG CCCCCCCCCCCCCCC | 22.72 | - | |
380 | Phosphorylation | TSEDSLFTPRPGEGA CCCCCCCCCCCCCCC | 24.55 | - | |
401 | Phosphorylation | SSRIRHRSEPQHPKE HHHCCCCCCCCCCCC | 47.72 | 21955146 | |
409 | Ubiquitination | EPQHPKEKPFMFNLD CCCCCCCCCCCCCCC | 50.08 | - | |
409 | Acetylation | EPQHPKEKPFMFNLD CCCCCCCCCCCCCCC | 50.08 | 25953088 | |
412 | Sulfoxidation | HPKEKPFMFNLDDEN CCCCCCCCCCCCCCC | 2.71 | 21406390 | |
422 | Phosphorylation | LDDENIRTSDV---- CCCCCCCCCCC---- | 26.02 | 21712546 | |
423 | Phosphorylation | DDENIRTSDV----- CCCCCCCCCC----- | 26.91 | 21712546 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PKHA2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PKHA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PKHA2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MPDZ_HUMAN | MPDZ | physical | 11802782 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184 AND SER-349, ANDMASS SPECTROMETRY. |